blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1018344

EP1018344 - HLA-restricted hepatitis B virus CTL epitopes [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  27.01.2006
Database last updated on 03.10.2024
Most recent event   Tooltip27.01.2006Application deemed to be withdrawnpublished on 15.03.2006  [2006/11]
Applicant(s)For all designated states
Epimmune Inc.
5820 Nancy Ridge Drive
San Diego, CA 92121 / US
[2002/01]
Former [2000/28]For all designated states
Epimmune, Inc.
6555 Nancy Ridge Drive, Suite 200
San Diego, California 92121 / US
Inventor(s)01 / Vitiello, Maria A.
7522 High Avenue
La Jolla, CA 92037 / US
02 / Chesnut, Robert W.
1473 Kings Cross Drive
Cardiff by the Sea, CA 92007 / US
[2000/28]
Representative(s)Cripps, Joanna Elizabeth, et al
Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
[N/P]
Former [2000/28]Cripps, Joanna Elizabeth, et al
Mewburn Ellis York House 23 Kingsway
GB-London WC2B 6HP / GB
Application number, filing date00102538.626.08.1992
[2000/28]
Priority number, dateUS1991074956826.08.1991         Original published format: US 749568
US1992082768229.01.1992         Original published format: US 827682
US1992087449127.04.1992         Original published format: US 874491
[2000/28]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP1018344
Date:12.07.2000
Language:EN
[2000/28]
Type: A3 Search report 
No.:EP1018344
Date:20.09.2000
[2000/38]
Search report(s)(Supplementary) European search report - dispatched on:EP03.08.2000
ClassificationIPC:C12N15/51, A61K39/29, G01N33/569, C07K7/00
[2000/35]
CPC:
C07K14/005 (EP); A61P31/12 (EP); A61P31/20 (EP);
A61K2039/57 (EP); A61K39/00 (EP,US); C07K2319/00 (EP);
C12N2730/10122 (EP) (-)
Former IPC [2000/28]A61K39/29, A61K47/48, C07K14/02, C07K19/00, C07K14/33, A61K39/08, G01N33/68
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2000/28]
TitleGerman:HLA-reduzierte CTL-Epitope gegen Hepatite B-Virus[2000/28]
English:HLA-restricted hepatitis B virus CTL epitopes[2000/28]
French:Epitopes du virus de l'hépatite B induisant une réponse CTL rétrécie par HLA[2000/28]
Examination procedure23.02.2000Examination requested  [2000/28]
21.01.2005Despatch of a communication from the examining division (Time limit: M06)
01.08.2005Application deemed to be withdrawn, date of legal effect  [2006/11]
23.09.2005Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2006/11]
Parent application(s)   TooltipEP92307764.8  / EP0534615
Fees paidRenewal fee
23.02.2000Renewal fee patent year 03
23.02.2000Renewal fee patent year 04
23.02.2000Renewal fee patent year 05
23.02.2000Renewal fee patent year 06
23.02.2000Renewal fee patent year 07
23.02.2000Renewal fee patent year 08
28.08.2000Renewal fee patent year 09
06.08.2001Renewal fee patent year 10
21.08.2002Renewal fee patent year 11
25.08.2003Renewal fee patent year 12
02.09.2004Renewal fee patent year 13
01.09.2005Renewal fee patent year 14
Penalty fee
Additional fee for renewal fee
31.08.200413   M06   Fee paid on   02.09.2004
31.08.200514   M06   Fee paid on   01.09.2005
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]EP0271302  (SCRIPPS CLINIC RES [US]);
 [X]EP0433242  (CESALPINO ANDREA FOND [IT]);
 [X]WO9109869  (MEDICAL RES COUNCIL [GB], et al);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.